Premium
DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG)
Author(s) -
Šimkovič M.,
Móciková H.,
Ďuraš J.,
Kamarádová K.,
Štěpánková P.,
Janíková A.,
Michalka J.,
Žák P.,
Belada D.,
Trněný M.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.107_2631
Subject(s) - medicine , epoch (astronomy) , vincristine , rituximab , diffuse large b cell lymphoma , regimen , prednisone , international prognostic index , median follow up , surgery , cyclophosphamide , lymphoma , oncology , chemotherapy , gastroenterology , stars , physics , astronomy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom